<VariationArchive VariationID="211656" VariationName="NM_133433.4(NIPBL):c.6707dup (p.Asn2236fs)" VariationType="Duplication" Accession="VCV000211656" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2015-10-05" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="207250" VariationID="211656">
      <GeneList>
        <Gene Symbol="NIPBL" FullName="NIPBL cohesin loading factor" GeneID="25836" HGNC_ID="HGNC:28862" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="36876769" stop="37066413" display_start="36876769" display_stop="37066413" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="36876860" stop="37065920" display_start="36876860" display_stop="37065920" Strand="+" />
          </Location>
          <OMIM>608667</OMIM>
          <Haploinsufficiency last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NIPBL">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-08-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NIPBL">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_133433.4(NIPBL):c.6707dup (p.Asn2236fs)</Name>
      <CanonicalSPDI>NC_000005.10:37048613:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="37048613" stop="37048614" display_start="37048613" display_stop="37048614" variantLength="1" positionVCF="37048613" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="37048715" stop="37048716" display_start="37048715" display_stop="37048716" variantLength="1" positionVCF="37048715" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>N2236fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.37048619dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.37048619dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.37048721dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.37048721dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_006987.2" sequenceAccession="NG_006987" sequenceVersion="2" change="g.176737dup">
            <Expression>NG_006987.2:g.176737dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015384.5" sequenceAccession="NM_015384" sequenceVersion="5" change="c.6707dup">
            <Expression>NM_015384.5:c.6707dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056199.2" sequenceAccession="NP_056199" sequenceVersion="2" change="p.Asn2236fs">
            <Expression>NP_056199.2:p.Asn2236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133433.4" sequenceAccession="NM_133433" sequenceVersion="4" change="c.6707dup" MANESelect="true">
            <Expression>NM_133433.4:c.6707dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_597677.2" sequenceAccession="NP_597677" sequenceVersion="2" change="p.Asn2236fs">
            <Expression>NP_597677.2:p.Asn2236fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277307" DB="ClinGen" />
        <XRef Type="rs" ID="797045778" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_133433.4(NIPBL):c.6707dup (p.Asn2236fs) AND Cornelia de Lange syndrome 1" Accession="RCV000194372" Version="7">
        <ClassifiedConditionList TraitSetID="548">
          <ClassifiedCondition DB="MedGen" ID="C4551851">Cornelia de Lange syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-10-05" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15318302</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19763162</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23505322</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29995837</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="548" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1016" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cornelia de Lange syndrome 1</ElementValue>
                <XRef ID="MONDO:0007387" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brachmann de Lange syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Typus degenerativus amstelodamensis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDLS</ElementValue>
                <XRef Type="MIM" ID="122470" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CDLS1</ElementValue>
                <XRef Type="MIM" ID="122470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C4551851" DB="MedGen" />
              <XRef ID="MONDO:0007387" DB="MONDO" />
              <XRef Type="MIM" ID="122470" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="459872" SubmissionDate="2015-09-15" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_133433.3(NIPBL):c.6707dup|Cornelia de Lange syndrome 1" />
        <ClinVarAccession Accession="SCV000248236" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2007</Attribute>
          <Citation>
            <ID Source="PubMed">18414213</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NIPBL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133433.3:c.6707dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cornelia de Lange syndrome 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7992969" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="25611170|MedGen:CN029798" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004306900" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15318302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19763162</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23505322</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29995837</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 211656). This variant has not been reported in the literature in individuals affected with NIPBL-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn2236Lysfs*18) in the NIPBL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NIPBL are known to be pathogenic (PMID: 15318302, 19763162, 23505322, 29995837).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NIPBL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.37048715_37048716insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN029798" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="459872" TraitType="Disease" MappingType="Name" MappingValue="Cornelia de Lange syndrome 1" MappingRef="Preferred">
        <MedGen CUI="C4551851" Name="Cornelia de Lange syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7992969" TraitType="Disease" MappingType="XRef" MappingValue="CN029798" MappingRef="MedGen">
        <MedGen CUI="C4551851" Name="Cornelia de Lange syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

